Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States.

Chokkalingam, Anand P; Hayden, Jennifer; Goldman, Jason D; Li, Hu; Asubonteng, Julius; Mozaffari, Essy; Bush, Christopher; Wang, Jocelyn R; Kong, Amanda; Osinusi, Anu O; Gottlieb, Robert L

Chokkalingam, Anand P; Hayden, Jennifer; Goldman, Jason D; Li, Hu; Asubonteng, Julius; Mozaffari, Essy; Bush, Christopher; Wang, Jocelyn R; Kong, Amanda; Osinusi, Anu O; Gottlieb, Robert L.

Afiliação

Chokkalingam AP; Real World Evidence, Gilead Sciences Inc, Foster City, California.
Hayden J; Division of Epidemiology, School of Public Health, University of California, Berkeley.
Goldman JD; Aetion Inc, New York, New York.
Li H; Swedish Center for Research and Innovation, Swedish Medical Center, Providence St Joseph Health, Seattle, Washington.
Asubonteng J; Division of Allergy and Infectious Diseases, University of Washington, Seattle.
Mozaffari E; Real World Evidence, Gilead Sciences Inc, Foster City, California.
Bush C; Real World Evidence, Gilead Sciences Inc, Foster City, California.
Wang JR; Medical Affairs, Gilead Sciences Inc, Foster City, California.
Kong A; Aetion Inc, New York, New York.
Osinusi AO; Aetion Inc, New York, New York.
Gottlieb RL; Aetion Inc, New York, New York.

JAMA Netw Open ; 5(12): e2244505, 2022 12 01.

Article em En | MEDLINE | ID: mdl-36454570

Assuntos

Tratamento Farmacológico da COVID-19; Adulto; Masculino; Estados Unidos/epidemiologia; Humanos; Idoso; Estudos Retrospectivos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: JAMA Netw Open Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google